YOUJIA BIO

Youjia (Hangzhou) Biomedical Technology Co., Ltd. was co-founded by multiple returned overseas Ph.D.s and a team with rich industrialization experience. With the starting point of meeting clinical needs, the company focuses on developing innovative drugs with independent intellectual property rights. It has currently established a mature nucleic acid drug development platform, including the NDDS intelligent nucleic acid drug design system, a well-developed delivery system, a comprehensive drug evaluation platform, and a polymer-based multi-formulation platform. The company also boasts a rich product pipeline, covering areas such as antiviral, anti-fibrotic, and cardiovascular diseases.